Synthesis of neoclerodane diterpenes and their pharmacological effects

18Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Salvinorin A is a neoclerodane diterpene that has been shown to be an agonist at kappa opioid receptors. Its unique structure makes it an attractive target for synthetic organic chemists due to its seven chiral centers and diterpene scaffold. This molecule is also interesting to pharmacologists because it is a non-serotonergic hallucinogen, and the first opioid ligand discovered that lacks a basic nitrogen. There have been several total synthesis approaches to salvinorin A, and these will be detailed within this chapter. Additionally, research efforts have concentrated on structure modification of the salvinorin A scaffold through semi-synthetic methods. Most modifications have focused on the manipulation of the acetate at C-2 and the furan ring. However, chemistry has also been developed to generate analogs at the C-1 ketone, the C-4 methyl ester, and the C-17 lactone. The synthetic methodologies developed for the salvinorin A scaffold will be described, as well as specific analogs with interesting biological activities. © 2010 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Lovell, K. M., Prevatt-Smith, K. M., Lozama, A., & Prisinzano, T. E. (2011). Synthesis of neoclerodane diterpenes and their pharmacological effects. Topics in Current Chemistry, 299, 141–185. https://doi.org/10.1007/128_2010_82

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free